Press Release Jul 13 2023

Published July 13, 2023 at 8:26 p.m. UTC

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated July 13, 2023, titled "FDA issues complete response letter for PDP-716 NDA due to inspection findings at third-party API manufacturing facility".

View Attachment

4:["$","main",null,{"className":"seo-shell seo-template-news","children":[["$","script",null,{"type":"application/ld+json","className":"seo-jsonld","dangerouslySetInnerHTML":{"__html":"{\"@context\":\"https://schema.org\",\"@type\":\"NewsArticle\",\"headline\":\"Press Release Jul 13 2023\",\"description\":\"Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated July 13, 2023, titled \\\"FDA issues complete response letter for PDP-716 NDA due to inspection findings at third-party API manufacturing facility\\\".\",\"url\":\"https://6ix.com/news/press-release-jul-13-2023-6\",\"datePublished\":\"2023-07-13T20:26:22.000Z\",\"articleSection\":\"Business\",\"about\":{\"@type\":\"Corporation\",\"name\":\"Sun Pharma Advanced Research Co. Ltd.\",\"url\":\"https://6ix.com/stock/nse-sparc/sun-pharma-advanced-research-company-limited\",\"tickerSymbol\":\"NSE:SPARC\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"6ix\",\"url\":\"https://6ix.com\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https://6ix.com/images/social-banner.png?v=2\"}}}"}}],["$","div",null,{"className":"seo-page-frame","children":[null,[["$","style",null,{"dangerouslySetInnerHTML":{"__html":"$d"}}],["$","div",null,{"dangerouslySetInnerHTML":{"__html":"$e"}}]]]}]]}] 7:null